VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.
Veramorph's investors include National Science Foundation, MassVentures, National Cancer Institute.
Veramorph is headquartered in Mansfield, United States.
VeraMorph is a pharmaceutical company that is developing an oral dosage technology based on polymers.
Veramorph is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Veramorph — Funding & Investors." VCBacked, October 15, 2025, https://www.vcbacked.co/company/veramorph. Accessed August 14, 2026.
VCBacked. (2025). Veramorph — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/veramorph
{{cite web |title=Veramorph — Funding & Investors |url=https://www.vcbacked.co/company/veramorph |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated